NO20020718D0 - Fremgangsmåter og sammensetninger nyttige for modulering av angionese ved å bruke proteinkinase RAF og RAS - Google Patents

Fremgangsmåter og sammensetninger nyttige for modulering av angionese ved å bruke proteinkinase RAF og RAS

Info

Publication number
NO20020718D0
NO20020718D0 NO20020718A NO20020718A NO20020718D0 NO 20020718 D0 NO20020718 D0 NO 20020718D0 NO 20020718 A NO20020718 A NO 20020718A NO 20020718 A NO20020718 A NO 20020718A NO 20020718 D0 NO20020718 D0 NO 20020718D0
Authority
NO
Norway
Prior art keywords
angionesis
ras
modulating
methods
protein kinase
Prior art date
Application number
NO20020718A
Other languages
English (en)
Other versions
NO20020718L (no
Inventor
John Hood
Brian Eliceiri
David A Cheresh
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20020718D0 publication Critical patent/NO20020718D0/no
Publication of NO20020718L publication Critical patent/NO20020718L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20020718A 1999-08-13 2002-02-12 Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS NO20020718L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14892499P 1999-08-13 1999-08-13
US21595100P 2000-07-05 2000-07-05
PCT/US2000/021842 WO2001012210A1 (en) 1999-08-13 2000-08-11 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras

Publications (2)

Publication Number Publication Date
NO20020718D0 true NO20020718D0 (no) 2002-02-12
NO20020718L NO20020718L (no) 2002-04-10

Family

ID=26846311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020718A NO20020718L (no) 1999-08-13 2002-02-12 Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS

Country Status (17)

Country Link
US (1) US20060040853A1 (no)
EP (1) EP1210099A4 (no)
JP (1) JP2003507337A (no)
KR (2) KR100805098B1 (no)
CN (1) CN1208087C (no)
AU (1) AU781877B2 (no)
BR (1) BR0013228A (no)
CA (1) CA2380966A1 (no)
CZ (1) CZ2002449A3 (no)
HK (1) HK1050856A1 (no)
HU (1) HUP0300923A3 (no)
MX (1) MXPA02001553A (no)
NO (1) NO20020718L (no)
PL (1) PL364928A1 (no)
RU (1) RU2257911C2 (no)
SK (1) SK2142002A3 (no)
WO (1) WO2001012210A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002223571A1 (en) * 2000-09-29 2002-04-08 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit, Gmbh Pharmaceutical compositions comprising polynucleotides encoding a raf protein
KR101737753B1 (ko) * 2007-03-12 2017-05-18 와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 페닐 아미노 피리미딘 화합물 및 이의 용도
JP2011510011A (ja) * 2008-01-14 2011-03-31 ジェネンテック， インコーポレイテッド Ｅｇｆｌ８アンタゴニストを使用する血管新生阻害方法
EP2329854A3 (de) * 2009-12-04 2014-02-19 Biotronik VI Patent AG Implantatbeschichtung mit Nukleinsäuren
CN102766601B (zh) * 2011-11-17 2015-12-16 中山大学肿瘤防治中心 含有可诱导型癌基因的细胞系及其建立方法、应用
WO2015185977A1 (en) * 2014-06-03 2015-12-10 Arturo Solis Herrera Animal models of corneal angiogenesis and corneal ectatic diseases, methods of producing, and methods of use thereof
RU2728870C2 (ru) * 2017-10-12 2020-07-31 Федеральное государственное бюджетное учреждение "Российский научный центр рентгенорадиологии" Министерства здравоохранения российской федерации (ФГБУ "РНЦРР" Минздрава России) Полипептиды для лечения онкологических заболеваний
US20230218710A1 (en) * 2020-04-15 2023-07-13 Cohbar, Inc. Method of treating coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618670A (en) * 1988-08-26 1997-04-08 The United States Of America As Represented By The Department Of Health & Human Services Detection method for c-raf-1 genes
US5156841A (en) * 1988-08-26 1992-10-20 United States Of America Anti-tumor vaccine
US5656612A (en) * 1994-05-31 1997-08-12 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
US5597719A (en) 1994-07-14 1997-01-28 Onyx Pharmaceuticals, Inc. Interaction of RAF-1 and 14-3-3 proteins
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
WO1998021585A1 (en) * 1996-11-15 1998-05-22 Cornell Research Foundation, Inc. Activated ras interaction assay
US6376471B1 (en) * 1997-10-10 2002-04-23 Johns Hopkins University Gene delivery compositions and methods

Also Published As

Publication number Publication date
EP1210099A1 (en) 2002-06-05
KR100759241B1 (ko) 2007-09-18
CN1378457A (zh) 2002-11-06
KR20070067210A (ko) 2007-06-27
WO2001012210A1 (en) 2001-02-22
AU6763300A (en) 2001-03-13
EP1210099A4 (en) 2006-01-18
KR20020032553A (ko) 2002-05-03
CZ2002449A3 (cs) 2002-08-14
MXPA02001553A (es) 2003-05-23
WO2001012210A9 (en) 2002-09-12
CN1208087C (zh) 2005-06-29
AU781877B2 (en) 2005-06-16
JP2003507337A (ja) 2003-02-25
HUP0300923A3 (en) 2005-12-28
KR100805098B1 (ko) 2008-02-20
HUP0300923A2 (hu) 2003-07-28
NO20020718L (no) 2002-04-10
PL364928A1 (en) 2004-12-27
CA2380966A1 (en) 2001-02-22
SK2142002A3 (en) 2002-07-02
US20060040853A1 (en) 2006-02-23
BR0013228A (pt) 2003-06-17
RU2257911C2 (ru) 2005-08-10
HK1050856A1 (en) 2003-07-11

Similar Documents

Publication Publication Date Title
NO992336D0 (no) Raf-kinase-inhibitorer
NO20032229L (no) Fremgangsmåter for behandling av p38kinase-assosierte tilstander og pyrrolotriazin forbindelser nyttige som kinase inhibitorer
CY2014034I2 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
DE60044004D1 (de) Verwendung von Omega-Carboxyaryl-substituierten Diphenylharnstoffen als raf-Kinase-Inhibitoren
NO20030826L (no) Fremgangsmåte for å modifisere substratoverflater og modifiserte substraterfremstilt derved
DE60021423D1 (de) 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren
ATE255575T1 (de) Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren
NO20021820D0 (no) Tyrosinkinaseinhibitorer
NO20014970L (no) Cyklisk protein-tyrosin-kinase-inhibitor
NO20012916D0 (no) Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser
IS6183A (is) Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO20025860D0 (no) Fremgangsmåte for opprettholding av formasjonsstabilitet i sanntid
NO20021736L (no) Nytt preparat og fremgangsmåte for stabilisering av det
DE60044061D1 (de) Sicherung von datenübertagungen
NO20005017D0 (no) Metoder og viskøse sammensetninger for behandling av brønner
NO20033580L (no) Fremgangsmåte og komposisjon til å hindre dannelse av hydrokarbonhydrater
DK1383733T3 (da) Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser
NO20015062L (no) Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser
NO20020718D0 (no) Fremgangsmåter og sammensetninger nyttige for modulering av angionese ved å bruke proteinkinase RAF og RAS
ITMI20001380A0 (it) Procedimento e dispositivo per variare il contenuto di memoria di apparecchi di comando.
NO20021739L (no) Petroleumreservoar simulering og karakteriseringssystem
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
NO20022057L (no) Fremgangsmåte og sammensetning for å behandle lungesykdommer
NO20004349L (no) Metoder og anordninger for modulering av immunresponsen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application